Profil
Robert Paul formerly worked at Nine Square Therapeutics, Inc., as Chief Executive Officer from 2022 to 2025, Genentech, Inc., as Assistant Director-Group Medical from 2015 to 2016, and Alector, Inc., as Chief Medical Officer from 2016 to 2021.
Dr. Paul received his doctorate degree from Ludwig-Maximilians-Universität München.
Tidigare kända positioner av Robert Paul
| Företag | Position | Slut |
|---|---|---|
Nine Square Therapeutics, Inc.
Nine Square Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Verkställande Direktör | 2025-02-01 |
| ALECTOR, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2021-10-11 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Företagsledare/Principal | 2016-10-01 |
Robert Pauls utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alector, Inc.
Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
Nine Square Therapeutics, Inc.
Nine Square Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
















